Effectiveness and safety of the tri-iodothyronine analogue Triac in children and adults with MCT8 deficiency: An international, single-arm, open-label, phase 2 trial - Groeneweg, S; Peeters, R P; Moran, C (Lancet Diabetes Endocrinol, 2019)
et al.